GT Biopharma, Inc. Note Agreements

24 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
GT Biopharma, Inc. Form of December 2020 / January 2021 Convertible Note Agreement
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2021
Amendment to Convertible Note between GT Biopharma, Inc. and Alto Opportunity Master Fund, SPC
Note Agreements
GT Biopharma, Inc.
Biotechnology
2021
GT Biopharma, Inc. Form of December 2020 / January 2021 Convertible Note Agreement
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2021
GT Biopharma, Inc. $500,000 Convertible Note Due January 31, 2021 with Alto Opportunity Master Fund
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Amendment to Convertible Note and Standstill Agreement between GT Biopharma, Inc. and Note Holder
Note Agreements
GT Biopharma, Inc.
Biotechnology
2020
Convertible Settlement Note Agreement between GT Biopharma, Inc. and Theorem Group, LLC (Due January 31, 2021)
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
GT Biopharma, Inc. Convertible Note Agreement (2020)
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Secured Convertible Note Agreement between GT Biopharma, Inc. and Noteholder
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
GT Biopharma, Inc. Secured Convertible Note Agreement
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
GT Biopharma, Inc. Convertible Note Due December 19, 2020
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
GT Biopharma, Inc. Convertible Note Agreement (April/May 2020)
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
GT Biopharma, Inc. Convertible Note Agreement, Dated January 30, 2020
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Secured Convertible Note Agreement between GT Biopharma, Inc. and Holder
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2019
GT Biopharma, Inc. Convertible Note Agreement (May 2019)
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2019
Secured Convertible Note Agreement between GT Biopharma, Inc. and Holder (February 2019)
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2019
GT Biopharma, Inc. Senior Convertible Note (Form of Note)
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2018
Note Conversion Agreement between GT Biopharma, Inc. and Multiple Investors (August 29, 2017)
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2017
Note Conversion Agreement between OXIS International, Inc. and Multiple Investors (January 8, 2016)
Note Agreements
GT Biopharma, Inc.
Biotechnology
DE
2016
Note Conversion Agreement between OXIS International, Inc. and Multiple Investors (January 8, 2016)
Note Agreements
GT Biopharma, Inc.
Biotechnology
DE
2016
Convertible Demand Promissory Note between Oxis International, Inc. and Bristol Investment Fund, Ltd. dated April 7, 2009
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2009
Secured Promissory Note between Percipio Biosciences, Inc. and Oxis International, Inc. dated December 11, 2008
Note Agreements
GT Biopharma, Inc.
Biotechnology
DE
2008
Renewal and Modification Promissory Note between Oxis International, Inc. and Fagan Capital Inc. dated June 2, 2006
Note Agreements
GT Biopharma, Inc.
Biotechnology
TX
2006
Promissory Note between OXIS International, Inc. and Fagan Capital Inc. dated March 31, 2006
Note Agreements
GT Biopharma, Inc.
Biotechnology
DE
2006
Promissory Note between OXIS International, Inc. and Steven T. Guillen dated March 10, 2006
Note Agreements
GT Biopharma, Inc.
Biotechnology
CA
2006